SIREN : 805313178
2N PHARMACIES is a French company founded 11 years ago, specialized in the sector Activités des sociétés holding. Based in SEIGNOSSE (40510), this company of category PME shows in 2023 a net income positive of 14 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 14 276 € | 34 283 € | -419 559 € | 475 182 € | 12 836 € | 81 714 € | -12 788 € | 39 277 € | 39 313 € | 26 844 € |
| EBITDA | -4 234 € | -980 € | -4 413 € | -3 987 € | -802 € | -602 € | -27 € | -1 057 € | N/C | N/C |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
In 2023, 2N PHARMACIES generates positive net income of 14 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2023: 27 k€ -> 14 k€.
-4 234 €
-4 234 €
14 276 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.0%
99.523%
0.0
In 2023, the debt ratio of 2N PHARMACIES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2023, the financial autonomy of 2N PHARMACIES (99.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2023, the repayment capacity of 2N PHARMACIES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 20949.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
20949.785
0.0
In 2023, the liquidity ratio of 2N PHARMACIES (20949.78) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2023, the interest coverage of 2N PHARMACIES (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 99 days. Excellent situation: suppliers finance 99 days of the operating cycle (retail model).
0 €
0 j
99 j
0 j
Based on 63 transactions of similar company sales
in 2023,
the value of 2N PHARMACIES is estimated at
133 163 €
(range 24 274€ - 197 603€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 63 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare 2N PHARMACIES with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of 2N PHARMACIES is not publicly disclosed (confidential accounts filed with INPI).
Yes, 2N PHARMACIES generated a net profit of 14 k€ in 2023.
The headquarters of 2N PHARMACIES is located in SEIGNOSSE (40510), in the department Landes.
The tax return of 2N PHARMACIES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
2N PHARMACIES operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.